News

Empower Clinics sees Q3 revenue nearly triple thanks to COVID-19 testing,higher MediSure sales

Nov 28, 2022 |

Empower Clinics Inc. (CSE:EPW, OTCQB:EPWCF) has posted sharply higher revenue of $1,573,809 for the third quarter, a 288% jump from the previous year thanks to the launch of its COVID-19 testing clinics for cruise ship passengers in Vancouver, Canada, and increased sales from MediSure. Revenue from Diagnostics and Technology, which includes the sale of MediSure products and COVID-19 testing, amounted to $1,289,808, compared to $160,955 in the same period a year earlier. COVID-19 testing...

read more

Empower Clinics sees 288% year over year growth in revenue as company releases Q3 numbers

Nov 28, 2022 |

Empower Clinics CEO Steven McAuley joined Steve Darling from Proactive to share news the company has announced positive 3rd Quarter financial numbers that showed a 288% increase year over year. McAuley saying total revenue was 1,573,809 for Q3 2022 compared to revenues of $405,707 for Q3 2021. The big increase was due in part to the launch of the company’s COVID-19 testing clinics for cruise ship passengers and increased sales from MediSure.

read more

Empower Clinics Reports Q3 2022 Results

Nov 28, 2022 |

288% year over year increase in revenue in Q3 2022 VANCOUVER, BC / ACCESSWIRE / November 28, 2022 / EMPOWER CLINICS INC (CSE:EPW)(Frankfurt:8EC)(OTCQB:EPWCF) ("Empower" or the "Company") an integrated healthcare company - serving patients through medical centers, telemedicine platforms, a medical device company, and a high complexity medical diagnostics laboratory - announced today it has filed its unaudited condensed interim consolidated financial statements and related Management's...

read more

Categories